HIGHLIGHTS
- who: Adam J. Mulkern from the Published in partnership with Nanyang Technological University have published the article: Microbiome-derived antimicrobial peptides offer therapeutic solutions for the treatment of Pseudomonas aeruginosa infections, in the Journal: Microbiomes offer a largely untapped resource of novel bioactives for biotechnological exploitation due to their complexity and diversity. The rumen is a prime example, whereby bacteria, fungi, protozoa and phage interact symbiotically to harvest energy from ingested feed1. However, like most microbiomes, competitive behaviour is displayed by rumen microbes when conditions require resilience for survival. Production of novel antimicrobials by the rumen microbes . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.